Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL

Autor:	Reinhold Munker, Rohitashva Agrawal, Maxwell M. Krem
Rok vydání:	2020
Předmět:	chemistry.chemical_compound chemistry Refractory business.industry Obinutuzumab Chronic lymphocytic leukemia Immunology Medicine business medicine.disease Autoimmune thrombocytopenia
Zdroj:	eJHaem. 1:368-370
ISSN:	2688-6146
DOI:	10.1002/jha2.78
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04af8112ec3d3231deafbdac0de95068 https://doi.org/10.1002/jha2.78 Zobrazit plný text záznamu Plný text